| Group A | Group B | Group C | Group D | Pvalue |
---|---|---|---|---|---|
Sex | Â | Â | Â | Â | Â |
Male | 163 | 54 | 235 | 6 | Â |
Female | 49 | 18 | 183 | 3 | <0.001 |
Age | Â | Â | Â | Â | Â |
≤59 | 82 | 21 | 264 | 6 |  |
>59 | 130 | 51 | 154 | 3 | <0.001 |
Stage | Â | Â | Â | Â | Â |
I | 48 | 10 | 69 | 1 | Â |
II | 80 | 23 | 93 | 2 | Â |
III | 66 | 30 | 211 | 3 | Â |
IV | 18 | 9 | 45 | 3 | <0.001 |
Degree of differentiation | Â | Â | Â | Â | Â |
Well + Moderate | 193 | 69 | 0 | 0 |  |
Poor + signet ring cell | 19 | 3 | 418 | 9 | <0.001 |
Location | Â | Â | Â | Â | Â |
Proximal | 99 | 45 | 111 | 1 | Â |
Distal | 104 | 24 | 269 | 7 | Â |
Total stomach | 9 | 3 | 38 | 1 | <0.001 |
Adjuvant chemotherapy | Â | Â | Â | Â | Â |
Yes | 144 | 48 | 297 | 5 | Â |
No | 50 | 15 | 76 | 1 | 0.505 |